Related Experiment Videos
Does postoperative pyrexia indicate malignant hyperthermia susceptibility?
1Leeds MH Investigation Unit, St James's University Hospital.
British Journal of Anaesthesia
|February 1, 1992
Abstract:
We are frequently asked if patients, in whom only postoperative pyrexia has been observed, should be considered as potentially susceptible to malignant hyperthermia (MHS). Of 30 patients of this type studied in this Unit, none was shown to be MHS. We consider that postoperative pyrexia alone is unlikely to signify MH.
Insights
Postoperative pyrexia alone is unlikely to indicate susceptibility to malignant hyperthermia (MHS). A study of 30 patients with only postoperative fever found none were MHS, suggesting this symptom is not a reliable indicator.
Area of Science:
- Anesthesiology
- Pharmacology
- Genetics
Background:
- Malignant hyperthermia (MHS) is a severe, unpredictable reaction to certain anesthetic agents.
- Postoperative pyrexia is a common occurrence, raising questions about its association with MHS.
Purpose of the Study:
- To determine if postoperative pyrexia alone is indicative of susceptibility to malignant hyperthermia (MHS).
Main Methods:
- A cohort of 30 patients with a history of only postoperative pyrexia was studied.
- Patients underwent evaluation for MHS susceptibility.
Main Results:
- None of the 30 patients studied were diagnosed with malignant hyperthermia susceptibility.
- The findings suggest a lack of correlation between isolated postoperative pyrexia and MHS.
Conclusions:
- Postoperative pyrexia as an isolated finding is unlikely to signify malignant hyperthermia susceptibility.
- Further research may be needed to fully elucidate the relationship between pyrexia and MHS.